{
  "main_header": {
    "sid": 1003496,
    "name": "Vineet Laborator",
    "stock_name": "Vineet Laborator",
    "full_name": "Vineet Laboratories Ltd",
    "name_url": "stocks-analysis/vineet-laborator",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "35.53",
    "chg": 0.36,
    "chgp": "1.02%",
    "dir": 1,
    "prev_price": "35.17",
    "mcapval": "32.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543298,
    "symbol": "VINEETLAB",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE505Y01010",
    "curr_date": "Apr 11, 12:50 PM",
    "curr_time": "23:59 PM",
    "bse_nse_vol": "7.52 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vineet-laborator-1003496-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Vineet Laboratories Faces Significant Challenges Amidst Declining Stock Performance and Operating Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vineet-laboratories-hits-52-week-low-amid-significant-operating-losses-and-weak-profitability-1647797",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/VineetLaborator_priceRelatedfactors_846769.png",
        "date": "2025-03-28 15:46:55",
        "description": "Vineet Laboratories, a microcap in the Pharmaceuticals & Drugs sector, has reached a new 52-week low, reflecting ongoing struggles with a 36.15% decline over the past year. The company has reported significant operating losses and negative results for three consecutive quarters, indicating serious financial challenges."
      },
      {
        "title": "Vineet Laboratories Faces Financial Struggles Amid Significant Stock Volatility and Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vineet-laboratories-hits-52-week-low-as-stock-drops-36-15-over-past-year-1647793",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/VineetLaborator_priceRelatedfactors_846771.png",
        "date": "2025-03-28 15:46:53",
        "description": "Vineet Laboratories, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low, reflecting a challenging year with a notable performance decline. The company faces financial difficulties, including operating losses and disappointing quarterly results, raising concerns about its long-term viability amid a bearish trend."
      },
      {
        "title": "Vineet Laboratories Faces Financial Struggles Amidst Significant Stock Decline and Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vineet-laboratories-hits-52-week-low-amid-broader-market-decline-and-poor-performance-1647795",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/VineetLaborator_priceRelatedfactors_846770.png",
        "date": "2025-03-28 15:46:53",
        "description": "Vineet Laboratories, a microcap in the Pharmaceuticals & Drugs sector, has reached a new 52-week low, reflecting a significant decline in performance over the past year. The company is grappling with operating losses, a poor ability to service debt, and consecutive quarters of negative results, indicating ongoing financial difficulties."
      },
      {
        "title": "Vineet Laboratories Reaches All-Time Low Amid Ongoing Financial Struggles",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vineet-laboratories-stock-hits-all-time-low-at-rs-30-6-amid-financial-struggles-1646708",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/VineetLaborator_priceRelatedfactors_845603.png",
        "date": "2025-03-28 15:07:01",
        "description": "Vineet Laboratories, a microcap in the Pharmaceuticals & Drugs sector, has shown volatility, recently hitting an all-time low. Despite a slight gain today, the stock has faced significant declines year-to-date and over the past three months, alongside ongoing financial challenges and negative quarterly results."
      },
      {
        "title": "Vineet Laboratories Faces Operational Challenges Amid Broader Market Recovery",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vineet-laboratories-hits-52-week-low-amid-significant-operating-losses-and-bearish-trend-1625908",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/VineetLaborator_priceRelatedfactors_820566.png",
        "date": "2025-03-27 12:55:21",
        "description": "Vineet Laboratories, a microcap in the Pharmaceuticals & Drugs sector, has faced significant volatility, recently hitting a 52-week low. The company has seen a steep annual decline and struggles with substantial operating losses and a weak debt servicing ability, while also reporting negative results for three consecutive quarters."
      },
      {
        "title": "Vineet Laboratories Hits All-Time Low Amid Ongoing Financial Struggles and Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vineet-laboratories-stock-hits-all-time-low-at-rs-33-15-amid-ongoing-decline-1401886",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/VineetLaborator_priceRelatedfactors_681463.png",
        "date": "2025-03-17 12:06:58",
        "description": "Vineet Laboratories, a microcap in the Pharmaceuticals & Drugs sector, has faced significant volatility, recently reaching an all-time low. The company has seen a sharp decline in stock performance over various time frames, raising concerns about its financial health, including operating losses and a poor ability to service debt."
      },
      {
        "title": "Vineet Laboratories Faces Financial Struggles Amid Significant Stock Activity and Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vineet-laboratories-hits-52-week-low-amid-continued-decline-and-operating-losses-1401187",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/VineetLaborator_priceRelatedfactors_681326.png",
        "date": "2025-03-17 11:15:20",
        "description": "Vineet Laboratories, a microcap in the Pharmaceuticals & Drugs sector, is nearing a 52-week low amid a significant decline of 14.49% over three days. The company faces financial challenges, including an operating loss and a poor EBIT to Interest ratio, alongside a substantial drop in operating profit and low Return on Equity."
      },
      {
        "title": "Vineet Laboratories Faces Significant Challenges Amidst Declining Stock Performance and Operating Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vineet-laboratories-hits-52-week-low-amid-significant-stock-decline-and-poor-performance-1345943",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/VineetLaborator_priceRelatedfactors_670861.png",
        "date": "2025-03-13 13:36:07",
        "description": "Vineet Laboratories, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low and has seen a significant decline over the past two days. The company faces challenges with operating losses, a low Return on Equity, and is trading below key moving averages, indicating ongoing difficulties."
      },
      {
        "title": "Vineet Laboratories Reaches All-Time Low Amidst Ongoing Financial Struggles",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vineet-laboratories-stock-hits-all-time-low-at-rs-35-1-amid-declining-performance-1344319",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/VineetLaborator_priceRelatedfactors_665933.png",
        "date": "2025-03-13 12:06:57",
        "description": "Vineet Laboratories, a microcap in the Pharmaceuticals & Drugs sector, is facing significant challenges, including a recent all-time low and a substantial decline in stock performance over the past month and year. The company has reported operating losses and negative results for three consecutive quarters, indicating a difficult market outlook."
      }
    ],
    "total": 24,
    "sid": "1003496",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/vineet-laboratories-1003496"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "25-Mar-2025",
      "details": "This is to inform that the trading window for dealing in the securities of the company will remain closed from 01st April 2025 till 48 hours after the announcement of Standalone Audited Financial Results for the Fourth Quarter and Financial Year ending on 31st March 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "15-Feb-2025",
      "details": "We are hereby submitting the Newspaper Advertisement in Financial Express (English language) and Nava Telangana (Telugu language) regarding the Un-audited Standalone financial results for the third quarter and nine months ended on December 31 2024",
      "source": "BSE"
    },
    {
      "caption": "Integrated Filing (Financial)",
      "datetime": "13-Feb-2025",
      "details": "The Board considered and approved un-audited financial results along with limited review report of the company for the third quarter and nine months ended on December 31 2024.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Vineet Laboratories Ltd has declared <strong>10%</strong> dividend, ex-date: 19 Sep 22",
          "dt": "2022-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Vineet Laboratories Faces Significant Challenges Amidst Declining Stock Performance and Operating Losses

2025-03-28 15:46:55

Vineet Laboratories, a microcap in the Pharmaceuticals & Drugs sector, has reached a new 52-week low, reflecting ongoing struggles with a 36.15% decline over the past year. The company has reported significant operating losses and negative results for three consecutive quarters, indicating serious financial challenges.

Read More

Vineet Laboratories Faces Financial Struggles Amid Significant Stock Volatility and Losses

2025-03-28 15:46:53

Vineet Laboratories, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low, reflecting a challenging year with a notable performance decline. The company faces financial difficulties, including operating losses and disappointing quarterly results, raising concerns about its long-term viability amid a bearish trend.

Read More

Vineet Laboratories Faces Financial Struggles Amidst Significant Stock Decline and Underperformance

2025-03-28 15:46:53

Vineet Laboratories, a microcap in the Pharmaceuticals & Drugs sector, has reached a new 52-week low, reflecting a significant decline in performance over the past year. The company is grappling with operating losses, a poor ability to service debt, and consecutive quarters of negative results, indicating ongoing financial difficulties.

Read More

Vineet Laboratories Reaches All-Time Low Amid Ongoing Financial Struggles

2025-03-28 15:07:01

Vineet Laboratories, a microcap in the Pharmaceuticals & Drugs sector, has shown volatility, recently hitting an all-time low. Despite a slight gain today, the stock has faced significant declines year-to-date and over the past three months, alongside ongoing financial challenges and negative quarterly results.

Read More

Vineet Laboratories Faces Operational Challenges Amid Broader Market Recovery

2025-03-27 12:55:21

Vineet Laboratories, a microcap in the Pharmaceuticals & Drugs sector, has faced significant volatility, recently hitting a 52-week low. The company has seen a steep annual decline and struggles with substantial operating losses and a weak debt servicing ability, while also reporting negative results for three consecutive quarters.

Read More

Vineet Laboratories Hits All-Time Low Amid Ongoing Financial Struggles and Volatility

2025-03-17 12:06:58

Vineet Laboratories, a microcap in the Pharmaceuticals & Drugs sector, has faced significant volatility, recently reaching an all-time low. The company has seen a sharp decline in stock performance over various time frames, raising concerns about its financial health, including operating losses and a poor ability to service debt.

Read More

Vineet Laboratories Faces Financial Struggles Amid Significant Stock Activity and Decline

2025-03-17 11:15:20

Vineet Laboratories, a microcap in the Pharmaceuticals & Drugs sector, is nearing a 52-week low amid a significant decline of 14.49% over three days. The company faces financial challenges, including an operating loss and a poor EBIT to Interest ratio, alongside a substantial drop in operating profit and low Return on Equity.

Read More

Vineet Laboratories Faces Significant Challenges Amidst Declining Stock Performance and Operating Losses

2025-03-13 13:36:07

Vineet Laboratories, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low and has seen a significant decline over the past two days. The company faces challenges with operating losses, a low Return on Equity, and is trading below key moving averages, indicating ongoing difficulties.

Read More

Vineet Laboratories Reaches All-Time Low Amidst Ongoing Financial Struggles

2025-03-13 12:06:57

Vineet Laboratories, a microcap in the Pharmaceuticals & Drugs sector, is facing significant challenges, including a recent all-time low and a substantial decline in stock performance over the past month and year. The company has reported operating losses and negative results for three consecutive quarters, indicating a difficult market outlook.

Read More

View All News